G6PD and non-autoimmune hemolytic anemia: The cyanosis following pamaquine therapy was caused by methaemoglobinaemia, and the sporadic severe haemolytic anaemia was later identified as resulting from the oxidant drug susceptibility of erythrocytes with reduced glucose-6-phosphate dehydrogenase (G6PD) activity.